29 research outputs found
MOESM4 of Accounting for equity considerations in cost-effectiveness analysis: a systematic review of rotavirus vaccine in low- and middle-income countries
Additional file 4: Appendix D. Figure S1. Trends over time in articles incorporating various equity criteria. Figure S2. Average number of indicators included in studies over time
MOESM2 of Accounting for equity considerations in cost-effectiveness analysis: a systematic review of rotavirus vaccine in low- and middle-income countries
Additional file 2: Appendix B. Indicators search strategy
MOESM1 of Accounting for equity considerations in cost-effectiveness analysis: a systematic review of rotavirus vaccine in low- and middle-income countries
Additional file 1: Appendix A. Norheim Checklist
Appendices_online_supp – Supplemental material for Exploring the Impact of Quality of Life on Survival: A Case Study in Total Knee Replacement Surgery
Supplemental material, Appendices_online_supp for Exploring the Impact of Quality of Life on Survival: A Case Study in Total Knee Replacement Surgery by Michelle Tew, Kim Dalziel, Michelle Dowsey, Peter F. Choong and Philip Clarke in Medical Decision Making</p
Characteristics of cancer patients with sepsis by malignancy type.
Characteristics of cancer patients with sepsis by malignancy type.</p
Variations in the 1-year cumulative excess cost by sex and age groups.
(A) Haematolgy. (B) Solid tumour. The dotted vertical line represents the excess cost presented in our main analysis (overall grouped average). Error bars represent the 95% confidence intervals.</p
Descriptive statistics of sepsis cases vs. matched controls by malignancy types.
(DOCX)</p
Descriptive statistics of sepsis cases vs. unmatched cases by malignancy types.
(DOCX)</p
Mean monthly cost of care by malignancy type.
(A) Haematolgy. (B) Solid tumour. The shaded area represents excess cost associated with sepsis, solid line represents mean monthly cost of care among sepsis (cases) and dotted line for no sepsis (controls).</p